Literature DB >> 31621051

Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy.

M Liu1, M Sum2, E Cong1, I Colon1, M Bucovsky1, J Williams1, A Kepley3, J Kuo4, J A Lee4, R M Lazar5, R Marshall6, S Silverberg1, M D Walker7.   

Abstract

PURPOSE: There are cognitive changes in primary hyperparathyroidism (PHPT) that improve with parathyroidectomy, but the mechanism of cognitive dysfunction has not been delineated. We assessed if cerebrovascular function is impaired in PHPT, improves post-parathyroidectomy and is associated with PTH level and cognitive dysfunction.
METHODS: This is an observational study of 43 patients with mild hypercalcemic or normocalcemic PHPT or goiter. At baseline, cerebrovascular function (dynamic cerebral autoregulation and vasomotor reactivity) by transcranial Doppler and neuropsychological function were compared between all three groups. A subset underwent parathyroidectomy or thyroidectomy, and was compared 6 months post-operatively.
RESULTS: Mean cerebrovascular and neuropsychological function was normal and no worse in PHPT compared to controls preoperatively. Higher PTH was associated with worse intracerebral autoregulation (r = - 0.43, p = 0.02) and worse cognitive performance on some tests. Post-parathyroidectomy, mood improved significantly, but changes did not differ compared to those having thyroidectomy (p = 0.84). There was no consistent improvement in cognition or change in vascular function in either surgical group.
CONCLUSIONS: Although higher PTH was associated with worse intracerebral autoregulation, cerebrovascular function, cognition and mood were normal in mild PHPT. PTX did not improve vascular or cognitive function. The observed improvement in mood cannot be clearly attributed to PTX. Notwithstanding the small sample size, the results do not support changing current criteria for parathyroidectomy to include cognitive complaints. However, the associations between PTH, cognition and cerebral autoregulation merit future studies in those with more severe hyperparathyroidism.

Entities:  

Keywords:  Autoregulation; Cognition; Primary hyperparathyroidism; Vascular stiffness; Vasomotor reactivity

Mesh:

Year:  2019        PMID: 31621051      PMCID: PMC7275118          DOI: 10.1007/s40618-019-01128-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  43 in total

Review 1.  Non classical complications of primary hyperparathyroidism.

Authors:  I Chiodini; E Cairoli; S Palmieri; J Pepe; M D Walker
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-06-18       Impact factor: 4.690

2.  Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls.

Authors:  Anne Kristine Amstrup; Lars Rejnmark; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2011-08-23       Impact factor: 6.664

Review 3.  Primary hyperparathyroidism: recent advances.

Authors:  Marcella D Walker; John P Bilezikian
Journal:  Curr Opin Rheumatol       Date:  2018-07       Impact factor: 5.006

4.  Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey.

Authors:  G B Talpos; H G Bone; M Kleerekoper; E R Phillips; M Alam; M Honasoge; G W Divine; D S Rao
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

5.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

7.  Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

Authors:  Elena Ambrogini; Filomena Cetani; Luisella Cianferotti; Edda Vignali; Chiara Banti; Giuseppe Viccica; Annalisa Oppo; Paolo Miccoli; Piero Berti; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

Review 8.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

9.  Surgical treatment of hyperparathyroidism improves health-related quality of life.

Authors:  David G Sheldon; Faye T Lee; Nancy J Neil; John A Ryan
Journal:  Arch Surg       Date:  2002-09

10.  Neuropsychological features in primary hyperparathyroidism: a prospective study.

Authors:  Marcella D Walker; Donald J McMahon; William B Inabnet; Ronald M Lazar; Ijeoma Brown; Susan Vardy; Felicia Cosman; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

View more
  3 in total

Review 1.  Cognitive deficits in primary hyperparathyroidism - what we know and what we do not know: A narrative review.

Authors:  Manju Chandran; Lydia Tan Li Yeh; Mechteld C de Jong; John P Bilezikian; Rajeev Parameswaran
Journal:  Rev Endocr Metab Disord       Date:  2022-08-22       Impact factor: 9.306

2.  The Associations of Serum Osteocalcin and Cortisol Levels With the Psychological Performance in Primary Hyperparathyroidism Patients.

Authors:  Shu-Min Wang; Yang He; Min-Ting Zhu; Bei Tao; Hong-Yan Zhao; Li-Hao Sun; Jian-Min Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-12       Impact factor: 5.555

3.  Functional magnetic resonance imaging in primary hyperparathyroidism.

Authors:  Yunglin Gazes; Minghao Liu; Melissa Sum; Elaine Cong; Jennifer Kuo; James A Lee; Shonni Silverberg; Yaakov Stern; Marcella Walker
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.